Avivagen (TSXV:VIV) EBIT per Share : C$-0.04 (TTM As of Jul. 2023)

View and export this data going back to 2003. Start your Free Trial

What is Avivagen EBIT per Share?

Avivagen's EBIT per Share for the three months ended in Jul. 2023 was C$-0.01. Its EBIT per Share for the trailing twelve months (TTM) ended in Jul. 2023 was C$-0.04.

During the past 3 years, the average EBIT per Share Growth Rate was 41.20% per year. During the past 5 years, the average EBIT per Share Growth Rate was 34.70% per year. During the past 10 years, the average EBIT per Share Growth Rate was 16.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Avivagen's EBIT per Share or its related term are showing as below:

TSXV:VIV' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -16.6 Med: 16.7 Max: 41.2
Current: 41.2

During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Avivagen was 41.20% per year. The lowest was -16.60% per year. And the median was 16.70% per year.

TSXV:VIV's 3-Year EBIT Growth Rate is ranked better than
83.92% of 858 companies
in the Drug Manufacturers industry
Industry Median: 7.8 vs TSXV:VIV: 41.20

Avivagen's EBIT for the three months ended in Jul. 2023 was C$-0.43 Mil.

Avivagen EBIT per Share Historical Data

The historical data trend for Avivagen's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Avivagen EBIT per Share Chart

Avivagen Annual Data

Trend

Oct13

Oct14

Oct15

Oct16

Oct17

Oct18

Oct19

Oct20

Oct21

Oct22

EBIT per Share

Get a 7-Day Free Trial

-0.14

-0.11

-0.09

-0.07

Avivagen Quarterly Data
	Oct18	Jan19	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23
EBIT per Share	Get a 7-Day Free Trial															-0.02	-0.02	-0.01	-0.01	-0.01

Avivagen EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Avivagen's EBIT per Share for the fiscal year that ended in Oct. 2022 is calculated as

	EBIT per Share		(A: Oct. 2022 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-4.298	/	66.028
=	-0.07

Avivagen's EBIT per Share for the quarter that ended in Jul. 2023 is calculated as

	EBIT per Share		(Q: Jul. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-0.427	/	77.695
=	-0.01

EBIT per Share for the trailing twelve months (TTM) ended in Jul. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.04

Avivagen (TSXV:VIV) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Avivagen EBIT per Share Related Terms

Thank you for viewing the detailed overview of Avivagen's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Avivagen (TSXV:VIV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Avivagen Inc (TSXV:VIV) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

VIVXF:USA

Address

100 Sussex Drive, Ottawa, ON, CAN, K1A 0R6

Website

https://www.avivagen.com

Avivagen Inc is a Canadian-based company operating in the healthcare sector. It develops science-based, natural health products for animals. It develops and commercializes products for livestock feeds to replace antibiotics for growth promotion and to help prevent disease by supporting the animal's health defenses. The company's products are based on OxC-beta Technology. Its geographical segments include the Philippines, which is the key revenue driver; Mexico; Thailand; United States; Malaysia; Taiwan; Brazil; and others.